|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
EP0378881B1
(en)
|
1989-01-17 |
1993-06-09 |
ENIRICERCHE S.p.A. |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
US7252829B1
(en)
*
|
1998-06-17 |
2007-08-07 |
Idm Pharma, Inc. |
HLA binding peptides and their uses
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
US5550214A
(en)
*
|
1994-02-10 |
1996-08-27 |
Brigham And Women's Hospital |
Isolated antigenic oncogene peptide fragments and uses
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
EP1162999B1
(en)
|
1999-03-19 |
2006-11-29 |
Glaxosmithkline Biologicals S.A. |
Vaccine against Streptococcus pneumoniae
|
|
JP2002541808A
(ja)
|
1999-04-09 |
2002-12-10 |
テクラブ， インコーポレイテッド |
ポリサッカリド結合体ワクチンのための組換えトキシンａタンパク質キャリア
|
|
CA2370413A1
(en)
|
1999-06-29 |
2001-01-04 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
EP1239866A4
(en)
*
|
1999-12-10 |
2005-02-09 |
Epimmune Inc |
INDUCTION OF HER2 / NEU CELLULAR IMMUNE RESPONSES USING PEPTIDE AND NUCLEIC ACID-CONTAINING COMPOSITIONS
|
|
JP2004511425A
(ja)
|
2000-02-08 |
2004-04-15 |
ザ ペン ステート リサーチ ファウンデーション |
免疫療法に使用されるインターロイキン１３受容体サブユニットアルファー２
|
|
WO2001062776A1
(en)
|
2000-02-23 |
2001-08-30 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
US7892559B2
(en)
|
2002-01-30 |
2011-02-22 |
Survac Aps |
Survivin-derived peptides and use thereof
|
|
CA2480008C
(en)
|
2002-03-22 |
2015-10-06 |
The Penn State Research Foundation |
Use of il-13 receptor subunit alpha 2 as an anti-cancer vaccine
|
|
EP1578432A4
(en)
|
2002-10-03 |
2008-07-30 |
Epimmune Inc |
HLA BINDING PEPTIDES AND USES THEREOF
|
|
WO2005076001A2
(en)
*
|
2004-02-06 |
2005-08-18 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
|
|
WO2006034334A2
(en)
|
2004-09-21 |
2006-03-30 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response
|
|
US7666622B2
(en)
|
2005-10-19 |
2010-02-23 |
Regeneron Pharmaceuticals, Inc. |
Monomeric self-associating fusion polypeptides and therapeutic uses thereof
|
|
BRPI0720280A2
(pt)
|
2006-12-11 |
2014-01-28 |
Wyeth Corp |
Métodos e composições para tratar e monitorar tratamento de desordens associadas à il-13
|
|
JP2010190572A
(ja)
*
|
2007-06-01 |
2010-09-02 |
Sapporo Medical Univ |
ＩＬ１３Ｒａ２に対する抗体およびこれを含む診断・治療薬
|
|
NZ600758A
(en)
|
2007-06-18 |
2013-09-27 |
Merck Sharp & Dohme |
Antibodies to human programmed death receptor pd-1
|
|
CN108117584B
(zh)
|
2007-08-20 |
2021-08-24 |
肿瘤疗法科学股份有限公司 |
Foxm1肽和包含foxm1肽的药剂
|
|
US20110182926A1
(en)
*
|
2008-08-12 |
2011-07-28 |
Nicola La Monica |
Minigene
|
|
WO2010077634A1
(en)
|
2008-12-09 |
2010-07-08 |
Genentech, Inc. |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
US20110033389A1
(en)
*
|
2009-04-29 |
2011-02-10 |
Zhifeng Chen |
Modified antibodies for passive immunotherapy
|
|
NZ599405A
(en)
|
2009-11-24 |
2014-09-26 |
Medimmune Ltd |
Targeted binding agents against b7-h1
|
|
WO2011140284A2
(en)
|
2010-05-04 |
2011-11-10 |
Fred Hutchinson Cancer Research Center |
Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses
|
|
EP4159226A1
(en)
|
2010-08-24 |
2023-04-05 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
|
|
EP2639299A1
(en)
|
2012-03-16 |
2013-09-18 |
Invectys |
Universal cancer peptides derived from telomerase
|
|
EP4361634A3
(en)
|
2012-03-19 |
2024-06-05 |
Stemline Therapeutics, Inc. |
Methods for treating and monitoring the status of cancer
|
|
WO2013148147A1
(en)
|
2012-03-26 |
2013-10-03 |
The U.S.A., As Represented By The Secretary Dept. Of Health And Human Services |
Dna methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
|
|
HUE056350T2
(hu)
|
2012-05-16 |
2022-02-28 |
Stemline Therapeutics Inc |
Rákos õssejt célzott rák elleni vakcinák
|
|
US20140141044A1
(en)
*
|
2012-11-12 |
2014-05-22 |
Dana-Farber Cancer Institute, Inc. |
Cord Colitis Syndrome Pathogen
|
|
CA3138788A1
(en)
|
2012-12-05 |
2014-06-12 |
Sola Biosciences Llc |
Protein expression enhancing polypeptides
|
|
US9764037B2
(en)
|
2012-12-06 |
2017-09-19 |
Victoria Link Limited |
Conjugate compounds
|
|
KR20160016725A
(ko)
*
|
2014-08-05 |
2016-02-15 |
주식회사 유영제약 |
암 세포에 과발현되는 IL13Rα2에 특이적으로 결합하는 키메라 항원 수용체로 변형된 T 세포
|
|
CA2976656A1
(en)
|
2015-02-16 |
2016-08-25 |
The Trustees Of The University Of Pennsylvania |
A fully-human t-cell receptor specific for the 369-377 epitope derived from the her2/neu (erbb2) receptor protein
|
|
US20180133327A1
(en)
|
2015-03-16 |
2018-05-17 |
Amal Therapeutics Sa |
Cell Penetrating Peptides and Complexes Comprising the Same
|
|
CN108026513A
(zh)
*
|
2015-03-31 |
2018-05-11 |
新加坡科技研究局 |
树突状细胞的抗原加载的方法和疫苗
|
|
EP3464630A1
(en)
|
2016-05-23 |
2019-04-10 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
Methods of diagnosing cancer using cancer testis antigens
|
|
EP3522916A2
(en)
|
2016-10-07 |
2019-08-14 |
Enterome S.A. |
Immunogenic compounds for cancer therapy
|
|
WO2018065628A2
(en)
|
2016-10-07 |
2018-04-12 |
Enterome |
Microbiota sequence variants of tumor-related antigenic epitopes
|
|
IL302345B2
(en)
|
2016-10-07 |
2024-12-01 |
Enterome S A |
Immunogenic compounds for cancer therapy
|
|
EP3694541A2
(en)
|
2017-10-09 |
2020-08-19 |
Enterome S.A. |
Microbiota sequence variants of tumor-related antigenic epitopes
|
|
HRP20230007T1
(hr)
|
2018-04-11 |
2023-03-03 |
Enterome S.A. |
Antigenski peptidi, namijenjeni sprječavanju i liječenju raka
|
|
WO2019197563A2
(en)
|
2018-04-11 |
2019-10-17 |
Enterome S.A. |
Immunogenic compounds for treatment of fibrosis, autoimmune diseases and inflammation
|
|
US20230105457A1
(en)
|
2019-10-16 |
2023-04-06 |
Enterome S.A. |
Immunogenic Compounds For Treatment Of Adrenal Cancer
|
|
EP4021487B1
(en)
|
2019-11-15 |
2023-12-27 |
Enterome S.A. |
Antigenic peptides for prevention and treatment of b-cell malignancy
|